These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Decreased renal α-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion. Asai O, Nakatani K, Tanaka T, Sakan H, Imura A, Yoshimoto S, Samejima K, Yamaguchi Y, Matsui M, Akai Y, Konishi N, Iwano M, Nabeshima Y, Saito Y. Kidney Int; 2012 Mar; 81(6):539-47. PubMed ID: 22217880 [Abstract] [Full Text] [Related]
6. Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy. Kang WL, Xu GS. Sci Rep; 2016 Jan 27; 6():19979. PubMed ID: 26813039 [Abstract] [Full Text] [Related]
7. Glutathione deficiency alters the vitamin D-metabolizing enzymes CYP27B1 and CYP24A1 in human renal proximal tubule epithelial cells and kidney of HFD-fed mice. Parsanathan R, Jain SK. Free Radic Biol Med; 2019 Feb 01; 131():376-381. PubMed ID: 30578920 [Abstract] [Full Text] [Related]
8. Vitamin D-VDR (vitamin D receptor) regulates defective autophagy in renal tubular epithelial cell in streptozotocin-induced diabetic mice via the AMPK pathway. Li A, Yi B, Han H, Yang S, Hu Z, Zheng L, Wang J, Liao Q, Zhang H. Autophagy; 2022 Apr 01; 18(4):877-890. PubMed ID: 34432556 [Abstract] [Full Text] [Related]
9. Klotho attenuates diabetic nephropathy in db/db mice and ameliorates high glucose-induced injury of human renal glomerular endothelial cells. Wang Q, Ren D, Li Y, Xu G. Cell Cycle; 2019 Apr 01; 18(6-7):696-707. PubMed ID: 30784349 [Abstract] [Full Text] [Related]
10. Sulodexide Protects Renal Tubular Epithelial Cells from Oxidative Stress-Induced Injury via Upregulating Klotho Expression at an Early Stage of Diabetic Kidney Disease. Liu YN, Zhou J, Li T, Wu J, Xie SH, Liu HF, Liu Z, Park TS, Wang Y, Liu WJ. J Diabetes Res; 2017 Apr 01; 2017():4989847. PubMed ID: 28929120 [Abstract] [Full Text] [Related]
11. Klotho inhibits PKCα/p66SHC-mediated podocyte injury in diabetic nephropathy. Jiang W, Xiao T, Han W, Xiong J, He T, Liu Y, Huang Y, Yang K, Bi X, Xu X, Yu Y, Li Y, Gu J, Zhang J, Huang Y, Zhang B, Zhao J. Mol Cell Endocrinol; 2019 Aug 20; 494():110490. PubMed ID: 31207271 [Abstract] [Full Text] [Related]